Celastrol stimulates IL-33 expression and activates the IL-33/ST2 pathway after ischemia by inducing beneficial M2 polarization of microglia/macrophages, thereby suppressing ischemia-induced inflammatory factors expression [229]. This evidence concerns the gene IL33 and ischemia.